GRI Bio Inc. (GRI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.06M
Last updated: Nov 17, 2026 at 4:15 PM ET
GRI Bio Inc. (GRI) Statistics
GRI Bio (GRI) has a market cap of $3.06M. It holds $9.47M more cash than debt, 309.48% of its market cap. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
| Market Cap | $3.06M |
|---|---|
| Latest price (Nov 17, 2026) | $1.34 |
Key Dates
The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 2, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 97.17% over 52 weeks and trades 22.09% below its 50-day average.
| Beta (1Y) | 0.63 |
|---|---|
| 52-Week Change | -97.17% |
| 1-Month Change | -7.59% |
| 3-Month Change | -22.54% |
| 6-Month Change | -39.91% |
| 5-Year Change | -100.00% |
| Total Return (1Y) | -97.17% |
| Total Return (3Y CAGR) | -96.94% |
| Total Return (5Y CAGR) | -95.28% |
| Return vs SPY (1Y) | -108.89% |
| Max Drawdown (1Y) | -97.76% |
| Max Drawdown (3Y) | -100.00% |
| Sharpe Ratio (1Y) | -2.48 |
| Correlation with SPY (1Y) | 0.06 |
| 50-Day Average | $1.72 |
| 200-Day Average | $2.03 |
| 52-Week Range | $1.36 to $64.12 |
| RSI (14 Days) | 39.4 |
| Average Volume (20 Days) | 48.90K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 10.21x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 10.21x |
|---|---|
| Quick Ratio | 10.21x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -88.63% and return on assets is -79.98% over the last 12 months.
| Return on Equity (ROE) | -88.63% |
|---|---|
| Return on Assets (ROA) | -79.98% |
Scores
GRI has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$1.00K |
| Operating Income | -$7.83M |
| Pretax Income | -$7.81M |
| Net Income | -$7.81M |
| Reported EPS (TTM) | -$119.82 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 90.27% of the $9.76M in total assets.
| Cash and Equivalents | $9.47M |
|---|---|
| Total Debt | $0 |
| Net Cash | $9.47M |
| Net Cash Per Share | $4.33 |
| Working Capital | $8.78M |
| Shareholder Equity | $8.81M |
| Book Value Per Share | $4.03 |
| Total Assets | $9.76M |
| Total Liabilities | $953.00K |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$9.58M |
|---|---|
| FCF Per Share | -$4.38 |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
GRI does not pay a dividend.
| Buyback Yield | -511.98% |
|---|---|
| Shareholder Yield | -511.98% |
Stock Splits
The last split was a 1-for-28 reverse split on Jan 26, 2026.
| Last Split Date | Jan 26, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:28 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About GRI
What is GRI's market cap?
GRI Bio has a market cap of $3.06M.
How many shares of GRI are outstanding?
GRI Bio has 2.19M shares outstanding.
Does GRI pay a dividend?
No. GRI Bio does not pay a dividend.
How much debt does GRI have?
GRI Bio has $0 of total debt and $9.47M of cash and equivalents, a net cash position of $9.47M.
GRI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors